I am featured in the April edition of PharmaVoice!!! The primary audience of PharmaVoice Magazine is made up of executive and corporate management from pharmaceutical and biotechnology organizations. It is vital for individuals with chronic illnesses to keep an open line of communication with such industries. Silence can often lead to deadly consequences.
In this issue, I shared my opinion about the importance of diversity within "Patient-Centric" clinical trials.
Check it out!